Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum
- PMID: 33386103
- DOI: 10.1016/j.ajog.2020.09.001
Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum
Erratum in
-
January 2021 (vol. 224, no. 1, pages B2, B3, B12, B13).Am J Obstet Gynecol. 2021 Jul;225(1):91. doi: 10.1016/j.ajog.2021.02.012. Epub 2021 Apr 19. Am J Obstet Gynecol. 2021. PMID: 33888304 No abstract available.
Abstract
Placenta accreta spectrum includes the full range of abnormal placental attachment to the uterus or other structures, encompassing placenta accreta, placenta increta, placenta percreta, morbidly adherent placenta, and invasive placentation. The incidence of placenta accreta spectrum has increased in recent years, largely driven by increasing rates of cesarean delivery. Prenatal detection of placenta accreta spectrum is primarily made by ultrasound and is important to reduce maternal morbidity associated with the condition. Despite a large body of research on various placenta accreta spectrum ultrasound markers and their screening performance, inconsistencies in the literature persist. In response to the need for standardizing the definitions of placenta accreta spectrum markers and the approach to the ultrasound examination, the Society for Maternal-Fetal Medicine convened a task force with representatives from the American Institute of Ultrasound in Medicine, the American College of Obstetricians and Gynecologists, the American College of Radiology, the International Society of Ultrasound in Obstetrics and Gynecology, the Society for Radiologists in Ultrasound, the American Registry for Diagnostic Medical Sonography, and the Gottesfeld-Hohler Memorial Ultrasound Foundation. The goals of the task force were to assess placenta accreta spectrum sonographic markers on the basis of available data and expert consensus, provide a standardized approach to the prenatal ultrasound evaluation of the uterus and placenta in pregnancies at risk of placenta accreta spectrum, and identify research gaps in the field. This manuscript provides information on the Placenta Accreta Spectrum Task Force process and findings.
Keywords: accreta; cesarean; increta; maternal morbidity; maternal mortality; percreta; placenta accreta spectrum; previa.
Copyright © 2020. Published by Elsevier Inc.
Similar articles
-
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8. Ultrasound Obstet Gynecol. 2022. PMID: 34225385 Free PMC article.
-
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.Ultrasound Obstet Gynecol. 2022 Sep;60(3):381-389. doi: 10.1002/uog.24889. Ultrasound Obstet Gynecol. 2022. PMID: 35247287 Free PMC article.
-
Lower uterine segment scar assessment at 11-14 weeks' gestation to screen for placenta accreta spectrum in women with prior Cesarean delivery.Ultrasound Obstet Gynecol. 2022 Jan;59(1):40-48. doi: 10.1002/uog.23734. Ultrasound Obstet Gynecol. 2022. PMID: 34254386
-
Morbidly adherent placenta.Semin Perinatol. 2013 Oct;37(5):359-64. doi: 10.1053/j.semperi.2013.06.014. Semin Perinatol. 2013. PMID: 24176160 Review.
-
A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders.Best Pract Res Clin Obstet Gynaecol. 2021 Apr;72:102-116. doi: 10.1016/j.bpobgyn.2020.06.007. Epub 2020 Jun 27. Best Pract Res Clin Obstet Gynaecol. 2021. PMID: 32698993 Review.
Cited by
-
Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging.Acta Obstet Gynecol Scand. 2022 Oct;101(10):1135-1145. doi: 10.1111/aogs.14420. Epub 2022 Jul 12. Acta Obstet Gynecol Scand. 2022. PMID: 35822244 Free PMC article.
-
Re: Correspondence on "Expectant management of viable cesarean scar pregnancies: a systematic review".Arch Gynecol Obstet. 2023 Dec;308(6):1915-1916. doi: 10.1007/s00404-023-06931-y. Epub 2023 Feb 4. Arch Gynecol Obstet. 2023. PMID: 36738317 No abstract available.
-
Relationship of Placental Vascular Indices with Macroscopic, Histopathologic, and Intraoperative Blood Loss in Placenta Accreta Spectrum Disorders.Obstet Gynecol Int. 2022 Jun 24;2022:2830066. doi: 10.1155/2022/2830066. eCollection 2022. Obstet Gynecol Int. 2022. PMID: 35784378 Free PMC article.
-
Placenta accreta spectrum.Nat Rev Dis Primers. 2025 Jun 5;11(1):40. doi: 10.1038/s41572-025-00624-3. Nat Rev Dis Primers. 2025. PMID: 40473652 Review.
-
Quality evaluation of clinical practice guidelines for placenta accreta spectrum disorders.Heliyon. 2024 Mar 22;10(7):e28390. doi: 10.1016/j.heliyon.2024.e28390. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38571606 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources